| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 272.93 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Direct oral anticoagulants emerge as the most innovative and promising drug toward preventing and treating cardiovascular disease, raising great interest among the scientific community. Numerous studies and meta-analysis generated much data clarifying clinicians' doubts; however, uncertainties remain regarding their use in particular groups such as patients with prosthetic valves, in valvular atrial fibrillation (defined as atrial fibrillation related to mitral rheumatic heart disease or prosthetic heart valves), among the elderly, in paraneoplastic thromboembolism, in pulmonary embolism with hemodynamic compromise, and scarcity of specific antidotes. This review article intends to condense the vast scientific production addressing new oral anticoagulants by focusing on their advantages and disadvantages when used on the elderly.
Descrição
Palavras-chave
Idoso Anticoagulantes Administração Oral
Contexto Educativo
Citação
Am J Ther. 2016 Aug 29. [Epub ahead of print]
